Author:
Fanet-Goguet Marianne,Martin Sylvie,Fernandez Christine,Fautrel Bruno,Bourgeois Pierre
Reference51 articles.
1. Agence Française de Sécurité Sanitaire des Produits de Santé (Afssaps). Enbrel®. Avis de la Commission de transparence du 2 octobre 2002. Available from URL: http://www.agmed.sante.gouv.fr [Accessed 2003 Apr 1]
2. Committee for Proprietary Medicinal Products. European Public Assessment Report (EPAR);European Agency for the Evaluation of Medicinal Products (EMEA);Enbrel®. Rev.,2002
3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein;Moreland;N Engl J Med,1997
4. Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial;Moreland;Ann Intern Med,1999
5. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate;Weinblatt;N Engl J Med,1999
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献